½ÃÀ庸°í¼­
»óǰÄÚµå
1732979

¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Æó¼â À¯Çüº°(¼±Ãµ¼º ½É°á¼ÕÆó¼â{¼ö±âº°(ASD,PDA,VSD), PFO Æó¼â, LAA Æó¼â), Áö¿ªº° ºÎ¹® ¹× °æÀï(2020-2030³â)

Heart Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Closure Type (Congenital Heart Defect Closure{By Technique( ASD,PDA,VSD)},PFO Closure, LAA Closure) By Region and Competition, 2020-2030F

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechSci Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀåÀº 2024³â¿¡ 28¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 10.39%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 51¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÉÀå Æó¼â ±â±â´Â ½É¹æÁ߰ݰá¼ÕÁõ(ASD), ³­¿ø°ø°³Á¸Áõ(PFO), ½É½ÇÁ߰ݰá¼ÕÁõ(VSD) µîÀÇ ±¸Á¶Àû ½ÉÀå °áÇÔÀ» Ä¡·áÇϱâ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç °³½É¼úÀ» ´ëüÇÏ´Â Àúħ½À ´ëü ÀǷḦ Á¦°øÇÕ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü »ó½Â, Ä«Å×Å͸¦ ÀÌ¿ëÇÑ ¼ö¼úÀÇ Ã¤¿ë Áõ°¡, µð¹ÙÀ̽º Àç·á³ª ¼³°èÀÇ Áøº¸, ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇØ ½ÃÀåÀº ±Þ¼ÓÇÏ°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. °æ Ä«Å×ÅÍÀû Æó¼â ±â±â ¹× °­È­µÈ È­»ó ±â¼ú µîÀÇ ±â¼ú Çõ½ÅÀº, ÀÌ·¯ÇÑ ¼ö±â¸¦ º¸´Ù Á¤È®Çϰí Àúħ½ÀÀ¸·Î ÇØ, ä¿ëÀ» ÇÑÃþ ´õ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿Ü»óÀÌ ÀûÀº Ä¡·á¿Í ȯÀÚÀÇ Àü±Í °³¼±À» ¿ä±¸ÇÏ´Â ¼¼°èÀÇ ¿òÁ÷ÀÓÀº ƯÈ÷ ÇコÄɾî ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÏ°í ½ÉÀå°áÇÔ Ä¡·á¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â Áö¿ª¿¡¼­ ÀÌµé ±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð(2024³â) 28¾ï 4,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð(2030³â) 51¾ï 4,000¸¸ ´Þ·¯
CAGR(2025-2030³â) 10.39%
±Þ¼ºÀå ºÎ¹® CHD Ŭ·ÎÀú
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

±â¼ú Áøº¸

ÁÖ¿ä ½ÃÀå °úÁ¦

»óȯ ¹®Á¦

ÁÖ¿ä ½ÃÀå µ¿Çâ

°æ Ä«Å×ÅÍ Æó¼â ±â±â

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°èÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
    • Æó¼â À¯Çüº°(CHD Æó¼â, PFO Æó¼â, LAA Æó¼â)
    • ±â¾÷º°(2024³â)
    • Áö¿ªº°
  • ½ÃÀå ¸Ê

Á¦6Àå ºÏ¹ÌÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
  • ºÏ¹Ì : ±¹°¡º° ºÐ¼®
    • ¹Ì±¹
    • ¸ß½ÃÄÚ
    • ij³ª´Ù

Á¦7Àå À¯·´ÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
  • À¯·´ : ±¹°¡º° ºÐ¼®
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º° ºÐ¼®
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ÀϺ»
    • È£ÁÖ

Á¦9Àå ³²¹ÌÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
  • ³²¹Ì : ±¹°¡º° ºÐ¼®
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÉÀå Æó¼â ±â±â ½ÃÀå Àü¸Á

  • ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø
  • ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦11Àå ½ÃÀå ¿ªÇÐ

  • ¼ºÀå ÃËÁø¿äÀÎ
  • °úÁ¦

Á¦12Àå ½ÃÀå µ¿Çâ ¹× ¹ßÀü

  • ÃÖ±Ù µ¿Çâ
  • Á¦Ç° Ãâ½Ã
  • ÇÕº´ ¹× Àμö

Á¦13Àå PESTEL ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

  • ¾÷°è ³» °æÀï
  • ½Å±Ô ÁøÀÔÀÇ °¡´É¼º
  • °ø±ÞÀÚÀÇ Èû
  • °í°´ÀÇ Èû
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °æÀï ±¸µµ

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology(Beijing) Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ±â¾÷ ¼Ò°³ ¹× ¸éÃ¥»çÇ×

AJY 25.06.04

The Global Heart Closure Devices Market was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.14 billion by 2030, growing at a CAGR of 10.39% during the forecast period. Heart closure devices are designed to treat structural heart defects such as atrial septal defects (ASDs), patent foramen ovale (PFO), and ventricular septal defects (VSD), providing a minimally invasive alternative to open-heart surgery. The market is expanding rapidly due to the rising prevalence of cardiovascular conditions, increasing adoption of catheter-based procedures, advancements in device materials and design, and the growing geriatric population. Technological innovations, such as transcatheter closure devices and enhanced imaging techniques, are making these procedures more precise and less invasive, further driving adoption. The global push for less traumatic interventions and improved patient outcomes continues to fuel demand for these devices, especially in regions with advanced healthcare infrastructure and rising awareness about heart defect treatments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.84 Billion
Market Size 2030USD 5.14 Billion
CAGR 2025-203010.39%
Fastest Growing SegmentCHD Closure
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Technological progress has significantly contributed to the expansion of the heart closure devices market. Developments in biomaterials and engineering have led to devices that are smaller, more flexible, and easier to implant, improving patient comfort and clinical outcomes. Innovations in catheter-based techniques enable minimally invasive procedures, reducing recovery time and surgical risks. Additionally, the integration of real-time imaging technologies such as 3D imaging and intracardiac echocardiography (ICE) allows for accurate visualization and placement of closure devices. These advancements have expanded treatment options for patients with congenital or acquired heart defects and have made these procedures more accessible and safer, which has helped boost overall market growth.

Key Market Challenges

Reimbursement Issues

Inconsistent and limited reimbursement policies represent a significant challenge in the heart closure devices market. Coverage and reimbursement vary widely across countries and healthcare systems, influencing patient access and the financial viability of procedures. In regions where reimbursement is limited or unclear, patients may face high out-of-pocket costs, deterring them from undergoing treatment. Healthcare providers also encounter administrative burdens and delays in securing reimbursement, which can limit their ability to offer these procedures consistently. These factors create disparities in treatment availability and restrict the adoption of heart closure devices, particularly in lower-income or publicly funded healthcare environments.

Key Market Trends

Transcatheter Closure Devices

Transcatheter closure devices are gaining prominence as the preferred approach for treating structural heart defects. These devices are delivered through catheters, offering a highly targeted and minimally invasive method of closure that reduces surgical complications and shortens recovery time. As precision and ease-of-use improve, these devices are increasingly seen as the standard of care, particularly for conditions like PFO and ASDs. Advanced delivery systems and real-time imaging facilitate accurate deployment, contributing to better procedural outcomes. The growing demand for less invasive cardiac procedures, combined with strong clinical efficacy, is driving widespread adoption of transcatheter closure technologies and accelerating their market penetration.

Key Market Players

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

Report Scope

In this report, the Global Heart Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Closure Devices Market, By Closure Type:

  • CHD Closure
  • PFO Closure
  • LAA Closure

Heart Closure Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Closure Devices Market.

Available Customizations

Global Heart Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Closure Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 5.2.2. By Company (2024)
    • 5.2.3. By Region
  • 5.3. Market Map

6. North America Heart Closure Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Heart Closure Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Closure Type
    • 6.3.2. Mexico Heart Closure Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Closure Type
    • 6.3.3. Canada Heart Closure Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Closure Type

7. Europe Heart Closure Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Heart Closure Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Closure Type
    • 7.3.2. Germany Heart Closure Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Closure Type
    • 7.3.3. United Kingdom Heart Closure Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Closure Type
    • 7.3.4. Italy Heart Closure Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Closure Type
    • 7.3.5. Spain Heart Closure Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Closure Type

8. Asia-Pacific Heart Closure Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 8.2.2. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Heart Closure Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Closure Type
    • 8.3.2. India Heart Closure Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Closure Type
    • 8.3.3. South Korea Heart Closure Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Closure Type
    • 8.3.4. Japan Heart Closure Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Closure Type
    • 8.3.5. Australia Heart Closure Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Closure Type

9. South America Heart Closure Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Heart Closure Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Closure Type
    • 9.3.2. Argentina Heart Closure Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Closure Type
    • 9.3.3. Colombia Heart Closure Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Closure Type

10. Middle East and Africa Heart Closure Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Heart Closure Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Closure Type
    • 10.3.2. Saudi Arabia Heart Closure Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Closure Type
    • 10.3.3. UAE Heart Closure Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Closure Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Gore & Associates, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Abbott Laboratories
  • 15.3. AtriCure Inc.
  • 15.4. Lifetech Scientific
  • 15.5. Occlutech
  • 15.6. Lepu Medical Technology (Beijing) Co., Ltd.
  • 15.7. Heartstitch
  • 15.8. SMT
  • 15.9. Cardiac, Inc.
  • 15.10. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦